Breaking News
March 25, 2019 - CPAP treatment can result in weight loss in people with sleep apnea and obseity
March 25, 2019 - Breast Density Categorization Varies With Screening Modality
March 25, 2019 - Researchers explore link between metal exposure and Parkinson’s symptoms
March 25, 2019 - Around one in hundred people has autism spectrum condition in China
March 25, 2019 - Research paves way for new standard of care to improve heart’s pump function
March 25, 2019 - Exposure to HIV virus, antiretroviral therapy before birth linked to obesity and asthma-like symptoms
March 25, 2019 - Transgender men preserve their fertility potential after one year of testosterone therapy
March 25, 2019 - Tighter Blood Pressure Control May Prevent Brain Lesions
March 25, 2019 - A reward now or later? Exploring impulsivity in Parkinson’s disease patients
March 25, 2019 - Financial incentives fail to increase completion rates of colorectal cancer screening tests mailed to patients
March 25, 2019 - New research program launched to highlight sexual harassment in academia
March 25, 2019 - Hemoglobin A1c blood test does not detect diabetes in most patients, shows study
March 25, 2019 - Wyss Technology licensed by Sherlock Biosciences to create affordable molecular diagnostics
March 25, 2019 - DWK Life Sciences launches KIMBLE GLS 80 Media Bottle and Multiport Cap System
March 25, 2019 - New study aims to reduce online sexual exploitation of children
March 25, 2019 - Want healthier eating habits? Start with a workout
March 25, 2019 - New approach to prescribing antibiotics could curb resistance
March 24, 2019 - Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis
March 24, 2019 - Prenatal DHA prevents blood-pressure increase from obesity during childhood
March 24, 2019 - Combined immunosuppression may be effective, safe in treating older patients with Crohn’s disease
March 24, 2019 - GSK sells health drinks arm, buys US cancer treatment firm
March 24, 2019 - Bacteria and innate immune factors in birth canal, cervix may be key to predicting preterm births
March 24, 2019 - IgG antibodies play unexpected role in atherosclerosis
March 24, 2019 - Sounds and vibrations are quite similar for the brain, finds new study
March 24, 2019 - Practices for Reducing COPD Hospital Readmissions Explored
March 24, 2019 - Could an eye doctor diagnose Alzheimer’s before you have symptoms?
March 24, 2019 - Enzyme inhibitor stops inflammation and neurodevelopmental disorders in mouse models
March 24, 2019 - Walk, Dance, Clean: Even a Little Activity Helps You Live Longer
March 24, 2019 - Americans used less eye care in 2014 versus 2008
March 24, 2019 - Study finds link between depression in 20s linked to memory loss in 50s
March 24, 2019 - New tool helps physiotherapy students to master complex fine motor skills
March 24, 2019 - The AMR Centre secures £2.3m funding boost
March 24, 2019 - Study examines effects of taking ondansetron during first trimester of pregnancy
March 24, 2019 - Researchers identify a more effective treatment for cancer
March 24, 2019 - Open-source solution for multiparametric optical mapping of the heart’s electrical activity
March 24, 2019 - New nanotechnology approach shows promise in treating triple negative breast cancer
March 24, 2019 - Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain
March 24, 2019 - Maternal deaths following C-section 50 times higher in Africa compared to high-income countries
March 24, 2019 - Apple watch could detect irregular heart beat says study
March 24, 2019 - Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology
March 24, 2019 - Girls should be encouraged to gain more ball skills, shows study
March 24, 2019 - Acute doses of synthetic cannabinoid can impair critical thinking and memory
March 24, 2019 - Presence of bacteria in urine does not always point to infection, shows study
March 24, 2019 - Scientists identify a new role for nerve-supporting cells
March 24, 2019 - Hidden differences between pathology of CTE and Alzheimer’s disease discovered
March 24, 2019 - Knowing causative genes of osteoporosis may open door to more effective treatments
March 24, 2019 - Toilet-seat based cardiovascular monitoring system getting ready to begin commercialization
March 24, 2019 - New model for intensive care identifies factors that send ill patients to ICU
March 24, 2019 - Recommendations Issued for HSCT in Multiple Myeloma
March 24, 2019 - Deep brain stimulation provides sustained relief for severe depression
March 24, 2019 - “Statistical significance” may soon be a thing of past?
March 24, 2019 - Researchers track effects of epigenetic marks carried by sperm chromosomes
March 24, 2019 - AHA News: Family Adopts Three Children With Three Different Heart Conditions
March 24, 2019 - Research into opioid painkillers could provide clues for safer drug development
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
New technique for identifying alcoholism puts treatment options at patients’ and providers’ fingertips

New technique for identifying alcoholism puts treatment options at patients’ and providers’ fingertips

image_pdfDownload PDFimage_print
Credit: Virginia Commonwealth University

Ninety percent of adults in the U.S. with an Alcohol Use Disorder don’t get treatment, according to the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health. To help make treatment more accessible, the NIH recently launched an online Alcohol Treatment Navigator, which gives providers and AUD patients information on evidence-based treatment options. The site also offers a brief survey to help a potential patient determine the range or severity of a problem.

Meeting patients where they are and then drawing them to the services that are most beneficial is the avenue by which more people will receive treatment and more AUD treatments will be developed, said Dace Svikis, Ph.D., a professor in the Virginia Commonwealth University Departments of Psychology and Psychiatry and the VCU Health Department of Obstetrics and Gynecology. Svikis is currently working on several projects researching the effects of alcohol, modernized treatments and appropriately diagnosing AUD.

VCU and VCU Health are home to several programs to help varying demographics cope with AUD, including the multidisciplinary Alcohol Research Center, which focuses on preclinical and clinical studies to identify the root cause of alcohol misuse and alcoholism. Tools such as the NIAAA’s Alcohol Treatment Navigator modernize how patients are treated and revolutionize how treatment is offered and administered, Svikis said.

VCU News recently talked with Svikis to learn how VCU and VCU Health are helping patients by making sure treatment is accessible to anyone in need.

How has alcoholism traditionally been diagnosed?

Traditionally, AUD, commonly referred to as alcoholism, is diagnosed when there is a problematic pattern of drinking that leads to clinically significant impairment or distress. To make a diagnosis, a trained clinician typically interviews the person about his or her drinking. The interviewer looks for evidence of several things:

  • Impaired control or drinking more than intended
  • Social impairment, such as conflicts with friends as a result of drinking or driving or operating machinery while inebriated
  • Physical impairment

In what way has alcoholism traditionally been treated?

Historically, alcoholism treatment was associated with either long-term residential treatment or Alcoholics Anonymous. Since that time, the menu of treatment options for AUD has expanded considerably. AUD treatment modalities range from inpatient medical detoxification to short- or long-term residential treatment, to various outpatient treatment options. Evidence-based behavioral treatments for AUD include brief intervention, typically delivered in medical care settings like an emergency department, as well as cognitive behavioral therapy, motivational enhancement therapy, contingency management and behavioral couples and family counseling among others. While less well-known, there are also three Food and Drug Administration-approved nonaddictive medications for AUD: naltrexone, acamprosate and disulfiram.

In your professional opinion, how potentially useful is a tool like the Alcohol Treatment Navigator?

It is often challenging for individuals with AUD to obtain accurate information about alcohol treatment options and different paths to recovery. The Alcohol Treatment Navigator provides easy-to-understand information about AUD as a chronic, relapsing disorder and the range of well-researched alcohol treatment options to consider. This tool also makes it easier to search for local treatment options and other recovery resources, with a toolkit of downloadable worksheets to guide individuals in their search for appropriate, quality care. In addition, this tool provides information and support resources to people living with AUD and their family members.

How can addiction and treatment professionals use this type of tool to benefit patients?

Across a variety of settings, the Alcohol Treatment Navigator is something health care providers can make available to patients who report alcohol problems and are looking for the best local treatment options. It also can educate interested professionals about AUD and increase awareness about the range of evidence-based treatment options that exist in this country.

What recent studies has VCU been part of regarding the treatment of alcoholism?

VCU is involved in a variety of projects focused on the identification and treatment of heavy and problem drinking. One longstanding commitment is to community-based research through the National Institute on Drug Abuse Clinical Trials Network. In collaboration with Johns Hopkins University and Friends Research Institute, VCU represents the Mid-Atlantic branch of CTN.

Over the last 15 years, VCU researchers have contributed to several multi-site national studies of interventions such as motivational interviewing, medication-assisted treatment, and even an employment-focused intervention to improve outcomes in treatment. More recently, Lauretta Cathers, Ph.D., a faculty member in the Department of Rehabilitation Counseling in the School of Allied Health Professions, and I participated in a multi-site CTN study of the Tobacco, Alcohol, Prescription medication, and other Substance use measure—TAPS. The purpose of the study was to develop and test TAPS as a tool that could address the need for a brief screening and assessment instrument that would not only include all commonly used substances, but also could be implemented in routine clinical practice.

Is diagnosing alcoholism on a full spectrum a new concept or something you’ve recognized throughout your career?

Early in my career, I was taught that physical dependence on alcohol was an important factor in determining alcoholism severity. Particularly, it was important to assess the need for hospitalization, with medical management of the detoxification process. Subsequently, two diagnostic options were made available, with alcohol abuse generally considered less severe than alcohol dependence.

There is now a single diagnostic category, Alcohol Use Disorder, with several symptoms determining severity for any given individual. This single continuum and the labelling of severity by number of symptoms will likely make it a more salient variable in both clinical care and future research. At least two symptoms must be present to make a diagnosis, whereby more symptoms indicate greater severity. Symptom severity ranges from mild, two to three symptoms, to moderate, four to five symptoms. More than six symptoms indicates a severe problem.

What specific programs are in place at VCU (including referral programs) to treat and counsel people and families battling Alcohol Use Disorder?

Within VCU Health, hospitalized patients with AUD receive consultative services that include assessment, brief intervention and, when appropriate, referral to treatment. Many outpatient clinics at VCU routinely screen their patients to identify those at risk for problem drinking. Those identified, or who self-disclose an alcohol problem, also receive information about local treatment resources. Community Services Boards offer outpatient alcohol and other drug abuse treatment as well as mental health counseling and services. In the Richmond community, they include Richmond Behavioral Health Authority, Chesterfield Mental Health Support Services and Henrico Area Mental Health & Developmental Services.

VCU Health also has an outpatient facility, the MOTIVATE Clinic, established, in part, in response to the opioid epidemic. Many individuals who abuse opioids have comorbid conditions, including alcoholism, which is why this type of treatment is critical. For students, The Wellness Resource Center – The Well— is available. The Well offers a variety of individual- and peer-focused educational programs on early intervention for alcohol and other substance use disorders. Particularly noteworthy is our RAMS in Recovery program, which is a nationally recognized, confidential, community-based resource for students in recovery from alcohol and other drugs. Also, through the College Behavioral and Emotional Health Institute and Spit for Science, we have a universitywide program focused on the study of alcohol, and other drug use, and emotional health outcomes in college populations.


Explore further:
APA releases new practice guideline on treatment of alcohol use disorder

Provided by:
Virginia Commonwealth University

About author

Related Articles